1. Piperazine ferulate attenuates gentamicin-induced acute kidney injury via the NF-κB/NLRP3 pathway
   Dan Li et al, 2022, Phytomedicine CrossRef
2. Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
   Zhiyong Long et al, 2024, Frontiers in Immunology CrossRef
3. Piperazine ferulate prevents high‑glucose‑induced filtration barrier injury of glomerular endothelial cells
   Yong-Yu Yang et al, 2021, Experimental and Therapeutic Medicine CrossRef
4. Hepatoprotective effect of diammonium glycyrrhizinate and neuroprotective effect of piperazine ferulate on AmB-induced liver and kidney injury by suppressing apoptosis in vitro and in vivo
   Xu He et al, 2024, Toxicon CrossRef
5. The Role of p66Shc in Diabetes: A Comprehensive Review from Bench to Bedside
   SeyedehFatemeh Mousavi et al, 2022, Journal of Diabetes Research CrossRef
6. Natural compounds efficacy in complicated diabetes: A new twist impacting ferroptosis
   Tingting Bao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment
   Shiyi Shen et al, 2024, Pharmaceutical Biology CrossRef
8. Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications
   Xi-Ding Yang et al, 2022, Frontiers in Endocrinology CrossRef
9. Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy
   Luxin Li et al, 2023, Frontiers in Endocrinology CrossRef
10. Therapeutic effects of natural compounds against diabetic complications via targeted modulation of ferroptosis
    Zhen Zhang et al, 2024, Frontiers in Pharmacology CrossRef